SIRT1 collaborates with ATM and HDAC1 to maintain genomic stability in neurons.
Level 5 - mechanism / opinion, no new human data
Preclinical laboratory and animal study (mechanistic/bench research)
PubMed 23852118 · doi:10.1038/nn.3460
What was done
Researchers investigated the role of the NAD(+)-dependent deacetylase SIRT1 in repairing DNA double-strand breaks (DSBs) in postmitotic neurons. They evaluated interactions between SIRT1, ataxia telangiectasia mutated (ATM), and HDAC1, analyzed nonhomologous end-joining repair pathway dynamics using HDAC1 acetylation mutants, and tested pharmacological SIRT1 activators in two mouse models of neurodegeneration.
What was found
The abstract reports no numerical values. Qualitatively, SIRT1 recruitment to DSBs was ATM-dependent, and SIRT1 in turn stimulated ATM autophosphorylation, activity, and DSB retention. SIRT1 bound and deacetylated HDAC1, stimulating enzymatic activity required for nonhomologous end-joining repair. Mimicking constitutive HDAC1 acetylation increased neuronal vulnerability to DNA damage, while pharmacological SIRT1 activators promoted HDAC1 deacetylation and reduced DNA damage in two mouse models of neurodegeneration.
Why it matters
This work identifies SIRT1 as an upstream regulator of the neuronal double-strand break response via ATM and HDAC1, providing a mechanistic rationale for targeting SIRT1 in neurodegenerative disorders.
Limits
The abstract provides no sample sizes, effect sizes, or quantitative confidence intervals. Findings are restricted to cellular assays and mouse models, without direct evaluation in human clinical neurodegeneration.
Cited by
- supports SIRT1 is a histone deacetylase that functions in genome gatekeeping and participates in repairing double-stranded DNA breaks.